Biomedical researchers have established and validated an optimized contrast-agent perfusion and micro-computed tomography protocol that successfully images the three-dimensional structural progression of embryonic chick hearts across developmental stages from embryonic day three to day ten. Reporting in BMC Biomedical Engineering under approval from the Qatar University Institutional Animal Care and Use Committee under protocol number QU-IACUC 022/2020, the investigative team evaluated a cohort of two hundred and forty chick embryos spanning Hamburger-Hamilton stages HH19 through HH36. The experimental findings demonstrated that while the duration of perfusion and the total volume of curable contrast agent required to saturate the cardiac chambers increased progressively alongside developmental maturation, the operational flow rate remained stable across all tested developmental stages. Quantitative micro-computed tomography reconstructions verified that this standardized physical delivery protocol maintained tissue integrity and chamber dilation, permitting detailed morphological assessments of cardiogenesis without inducing vascular rupture.
To establish the empirical baseline for the protocol, the investigators analyzed thirty distinct avian embryos for each individual measurement at every evaluated embryonic day. The fertilized eggs, procured from the Arab-Qatari Poultry Farm in Doha, Qatar, were maintained in a cooler at thirteen degrees Celsius for up to seven days as a precautionary storage measure before active incubation. Standard incubation was conducted at thirty-seven degrees Celsius with a fully filled water reservoir maintaining sixty percent relative humidity, accompanied by egg rocking during the initial three days. Because embryonic chicks reside on the yolk sac during the first five days before descending into the middle of the egg, incubation procedures required careful handling on day three. The eggs were set horizontally on racks for at least two minutes to permit the embryo to migrate to the top of the eggshell before microsurgical preparation commenced.
Microsurgical access to the growing avian embryo was executed at embryonic day three. After sanitizing the outer eggshell with seventy percent ethanol, a small access hole was introduced at the pointed pole of the eggshell. Working at an insertion angle of approximately forty-five degrees, the researchers positioned a syringe needle within the egg and aspirated between five and six milliliters of albumin. A secondary aperture was created adjacent to a demarcated circle on the shell, followed by careful windowing using curved surgical scissors to prevent accidental contact between the cutting blades and the underlying yolk. Eggs exhibiting lack of fertilization, adhesion to the shell, or abnormal developmental arrest were discarded, while viable specimens were sealed with transparent tape to arrest dehydration and returned to a bench-top incubator maintained at thirty-seven point five degrees Celsius and sixty percent humidity.
Precise delivery of the radiopaque compound required the formulation of a specialized Microfil cast mixture derived from compound ratios refined in prior cardiovascular investigations. For each individual heart perfusion procedure, the team prepared a total volume of five hundred microliters of the Microfil mixture, combining four hundred microliters of diluent, seventy-five microliters of Microfil dye, and twenty-five microliters of curing agent, establishing an eighty percent, fifteen percent, and five percent volumetric ratio. This chemical formulation established a working polymerization window of approximately thirty minutes at ambient room temperature, providing sufficient latency to complete intraventricular delivery before the curable polymer solidified. In parallel, custom glass injection capillaries were pulled from four-millimeter thin-wall glass tubing with an outer diameter of one point five millimeters and an inner diameter of one point twelve millimeters, utilizing a Narishige PC-100 automated double-pulling pipette puller.
Fabrication of the glass delivery needles required calibrated thermal settings on the automated puller to produce tip geometries precisely proportioned to the advancing anatomical dimensions of each developmental stage. The automated instrument was configured with two heavy heater blocks and one light heater block, with micromanipulator plates designated as Plate 1 and Plate 2 fixed at three point five millimeters and seven millimeters. Progressive increments in the puller heater temperature produced commensurate enlargements in capillary tip diameter, generating stage-specific needles tailored respectively for stages HH19 and HH24 at days three and four, stage HH27 at day five, stages HH29 and HH31 at days six and seven, stages HH34 and HH35 at days eight and nine, and stage HH36 at embryonic day ten.
Active perfusion experiments were conducted sequentially across embryonic days three through ten without subjecting the avian embryos to pre-procedural chemical euthanasia. Preserving spontaneous cardiac contractions was an essential design criterion, ensuring that physiological ventricular pumping actively propelled the radiopaque dye into the outflow tract and throughout the vascular network. The embryo was separated from the yolk by severing surrounding vitelline blood vessels at the maximum practical distance from the embryonic body to maintain an external fluid reservoir against abrupt pressure fluctuations. Following transfer to a petri dish under a Zeiss stereomicroscope equipped with an Axiocam ERc 5s digital imaging camera, the glass capillary was coupled to a Narishige manual micro-pump via a microneedle assembly and directed through the pericardium into a cardiac ventricle, supported by topical drops of warm phosphate-buffered saline to sustain myocardial beating.
The physical injection of the contrast agent was regulated within a low delivery range between two point eight and six point eight microliters per minute to safeguard vascular architecture. Procedural timing commenced when the glass tip entered the ventricle and the initial droplet entered the chamber, concluding once the heart, major intraembryonic vessels, and extraembryonic vitelline branches were fully filled, with filling of vessels proximal to the eye serving as the operational stopping benchmark. Perfusion volume was quantified by marking the linear displacement of contrast fluid within calibrated micro-tubing using a waterproof marker, calculating absolute volume from internal tubing diameter and fluid length, while flow rate was derived by dividing infused volume by elapsed duration. Over-perfusion was strictly avoided to prevent vessel bursting, ensuring sustained luminal distension while the injected compound polymerized undisturbed in petri dishes for thirty minutes at room temperature before specimens were immersed in four percent paraformaldehyde.
Quantitative measurements confirmed that the physiological expansion of the developing avian heart dictated substantial shifts in required perfusion parameters across the incubation timeline. Perfusion duration increased progressively from approximately four minutes at embryonic day three (stage HH19) to more than twenty-six minutes at embryonic day ten (stage HH36). In parallel, the mean volume of contrast dye needed to saturate the cardiac chambers expanded from eleven point eight microliters at day three to a peak of one hundred and sixty-six point three microliters at day ten, directly mirroring the extensive volumetric growth of the myocardium. In contrast to these rising volume and duration curves, the measured flow rates did not vary significantly across developmental stages, remaining bounded between three point eight and six point eight microliters per minute as intentional hydraulic boundaries preserved the structural integrity of the embryonic vessels.
Following chemical fixation in four percent paraformaldehyde for twenty-four hours, stabilized specimens were transferred into phosphate-buffered saline tubes, utilizing three-milliliter cryotubes for days three through five and fifteen-milliliter centrifuge tubes containing stabilizing foam inserts for days six through ten. X-ray imaging was performed at Texas A&M University at Qatar using a Thermo-Fisher Mk1 Heliscan micro-computed tomography scanner operating a space-filling helical trajectory at beam energies between eighty and ninety kiloelectron volts. Beam-hardening distortions were attenuated through a zero point one millimeter stainless steel source filter and a two millimeter aluminum detector filter, yielding reconstructed voxel resolutions between seven point six and fourteen micrometers. Reconstructed volumetric datasets were denoised with edge-preserving non-local means filters, segmented into binary image sets through interactive thresholding in 3D Slicer, and refined in MeshMixer software to isolate atrial and ventricular geometries.
Three-dimensional anatomical surface renderings demonstrated the developmental trajectory of cardiac morphogenesis, capturing the transition from an unseptated tubular configuration at day three through the emergence of internal septation at day five and the attainment of nearly complete chamber septation by day ten. The authors noted several operational limitations, emphasizing that restricting analysis to days three through ten omitted earliest and latest developmental events, while prolonged egg storage at thirteen degrees Celsius could compromise viability. Technical challenges included risk of vascular rupture during micro-dissection, manual thresholding subjectivity during image segmentation, and instances at day ten where extended perfusion durations approached or exceeded the thirty-minute polymerization limit of the Microfil compound. Nonetheless, the authors concluded that this standardized protocol provides reproducible parameters that can be adapted to other developmental models, including zebrafish, by scaling perfusion metrics to vascular lumen volumes.
Subject of Research: Optimized micro-CT contrast agent perfusion protocol for chick embryo cardiogenesis
Article Title: An optimized CT-dense agent perfusion and micro-CT imaging protocol for chick embryo developmental stages
Article References: Naïja, A., Mutlu, O., Khan, T., Seers, T. D., & Yalcin, H. C. (2024). An optimized CT-dense agent perfusion and micro-CT imaging protocol for chick embryo developmental stages. BMC Biomedical Engineering, 6(1), Article 3. https://doi.org/10.1186/s42490-024-00078-w
Image Credits: AI Generated
DOI: 10.1186/s42490-024-00078-w
Keywords: micro-CT imaging, chick embryo, cardiogenesis, contrast agent perfusion, developmental biology, Microfil cast, three-dimensional reconstruction, cardiovascular morphology, optimized, CT-dense, agent, perfusion
News Source: Gregory Coleman. (November 10, 2026). Optimized Perfusion Protocol Enhances Micro-CT Imaging of Chick Embryo Hearts. Scienmag.



